SARS-CoV-2 therapeutics: how far do we stand from a remedy?

ABSTRACT: The SARS-CoV-2 has affected millions worldwide and has posed an immediate need for effective pharmacological interventions. Ever since the outbreak was declared, the medical fraternity across the world is facing a unique situation of offering assistance and simultaneously generating reliable data with high-quality evidence to extend the scope of finding a treatment. With no proven vaccine or other interventions available hitherto, there is a frenzied urgency of sharing preliminary data from laboratories and trials to shape a global response against the virus. Several clinical trials with investigational and approved repurposed therapeutics have shown promising results. This review aims to compile the information of the reported molecules approved for emergency use and those under clinical

SUBMITTER: Singh A 

PROVIDER: S-EPMC7778692 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature